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Introduction
The differential radiobiological responses displayed by normal and tumor tissues exemplified by the five R's of radiotherapy (Asur et al 2013) , have led to the development of fractionated radiotherapy protocols where treatments are delivered as a series of equally sized fractions over a period of weeks. These treatment schedules are based largely on empirical observations and are currently being challenged as both hypo-and hyperfractionated schedules become increasingly common practice.
Concurrently, there have been significant technological developments which have improved the conformality of dose to the tumor target whilst reducing dose in nearby normal tissue (Joiner and van der Kogel 2009 ). As a consequence, some areas outside of the primary treatment fields may experience steep dose gradients while others may receive a non-trivial dose bath due to scattered photons from multiple beams.
Advanced radiotherapy techniques are currently being developed considering the spatiotemporal changes which can affect the biological outcome. Incorporation of these radiobiological responses into the treatment planning to further improve treatment control demands new translational input.
Radiation induced bystander signalling has been observed in a range of cell lines, tissue models and in vivo (Mancuso et al 2008) with an important characteristic being the dose-response relationship. It has been reported that the signal becomes saturated at a relatively low dose of irradiation (commonly below 1 Gy delivered to the target cells) and in many models, the low dose bystander response has been found to be almost equally effective as that of direct irradiation O'Sullivan 2010, Mothersill and Seymour 2004) .
There have been extensive reports for the importance of bystander effects in vitro (Liu et al 2006 , Schettino et al 2005 , Butterworth et al 2011 using for example precise microbeam approaches to selectively irradiate specific cells. More recently, experimental studies have investigated signalling effects using intensity modulated deliveries from medical linear accelerators (Suchowerska et al 2005 , Mackonis et al 2007 . Previous work (Ebert et al 2010 , McMahon et al 2013a has suggested that these effects are relevant not only out-of-field, but also contribute to survival of directly irradiated cells, emphasizing their relevance not only to organs at risk but also in tumour volumes.
A recent model (McMahon et al 2013b) shows the predicted clinical relevance of intercellular communication in treatment planning by incorporating bystander signalling as part of the biological effective dose. The model predicts a significant difference in the signalling adjusted dose and physical dose for a large volume, with the highest impact for nearby organs at risk.
Additionally, high dose regions will see a decrease in the biologically effective dose with significant differences (i.e., from 74 to 71 Gy) in IMRT plans. However, the model considers the radiation being delivered as a single acute dose and does not consider cell recovery and possible complications due to the intercellular signalling between fractions.
Because of the well-established impact of fractionation in clinical settings and the increasing interest in alternative fractionation schedules, an understanding of the impacts of fractionation on intercellular signalling effects is important to understand the role these effects may have in advanced therapies. This study aims to address this need by determining the impact of dose fractionation on in-and out-of-field responses of DNA damage and survival.
Materials and Methods

Cell culture
Experiments were conducted using two human cell lines, the breast adenocarcinoma cell line, MCF-7 and the transformed fibroblast cell line, AGO-1522. Cell lines were selected as malignant and transformed models with previously reported radiosensitivities and alpha/beta ratios. MCF-7 cells, obtained from Cancer Research UK, were maintained in Dulbecco's Modified Eagle's Medium (Sigma Aldrich, UK) supplemented with 10% fetal bovine serum (PAA Laboratories, UK) and 1% penicillin/streptomycin (Gibco-Invitrogen, UK). AGO-1552 cells obtained from the Coriell Institute for Medical Research (Camden, NJ, USA) and maintained in α-modified Eagle's Medium (Lonza, UK) supplemented with 20% fetal bovine serum (PAA Laboratories, UK) and 1% penicillin/streptomycin. All cell lines were maintained at 37°C in a humidified atmosphere of 5% CO2.
Clonogenic survival assay
Cell survival was determined by clonogenic assay as previously described (Trainor et al 2012a). Cells were plated and allowed to adhere overnight before being irradiated with a single, acute exposure or two equally sized fractions separated by time intervals from 4 to 48 hours and incubated at 37°C between irradiations. Exposures were performed under uniform and shielded beam configurations. For the more radioresistant MCF-7 cell line, doses between 0-8 Gy were used, while for the more radiosensitive cell line (AGO-1552) doses between 0-6 Gy were used. For each experiment, unexposed controls were prepared and treated as sham exposures. Experiments were conducted under standard culture conditions or in the presence of the free radical scavenger, dimethyl sulphoxide (DMSO, Sigma Aldrich, UK) at a concentration of 5% in culture media added 2 hours prior to irradiation and removed and replaced with complete culture medium 24 hours after irradiation. Cultures were incubated for 10-14 days before staining with 0.5% crystal violet in 70% methanol.
DNA damage analysis by immunofluorescence microscopy
Cells were plated at a density of 1.5 x 10 5 cells onto microscope slides in P90 cell culture dishes and allowed to adhere overnight before being irradiated (acute or split exposure) with a total dose of 2 Gy separated by times ranging from 30 minutes to 24 hours. Exposures were performed under uniform and shielded beam configurations and cells fixed using 4% paraformaldehyde solution at time intervals up to 24 hours. DNA damage was quantified by immunofluorescence detection of γH2AX and 53BP1 as previously described (Trainor et al 2012b) . Nuclear foci were manually scored for 100 cells per slide using a Zeiss Axiovert 200 M microscope (Carl Zeiss MicroImaging, LLC, USA).
Irradiation setup and validation of experimental design
As cellular responses to radiation exposure are determined by a variety of parameters including Ionisation chamber (PTW Freiburg) measurements were made in conjunction with film measurements to define the shielded and penumbra regions. The dose delivered to the out-offield region was estimated as the average scattered dose to that region. For a 50% modulated field the scattered dose received out-of-field was determined to be 3% of the total dose delivered to the in-field region.
Data analysis
For each of the clonogenic experiments, survival fractions were calculated as the ratio between the number of surviving colonies in the irradiated flask relative to the number of colonies in a sham irradiated flask normalized to the number of cells plated.
The survival curves have been fitted using the linear quadratic model where the αD term represents cell death due to complex single event hits, and βD 2 is attributed to multiple track events; the out-of-field survival was fitted using a single exponential function where d is the scattered dose under the shielding. Recovery kinetics for 8 and 6 Gy doses were fitted to the exponential decay function ⁄ where λ is the characteristic time.
DNA damage analysis considered foci number relative to sham irradiated control numbers. The onset and repair curve for single dose irradiation was fitted to the following equation 1 , where t is the incubation time after irradiation, r the rate at which foci appear, and b the DNA damage decay rate. The fractionated exposure foci decay curves for uniform field and in-field were fitted to the single phase exponential decay where t1 is the time interval between the fractions, y0 is the number of foci induced by the second fraction, b the damage decay rate and A the number of foci from the first fraction.
All experiments were carried out in duplicate, on at least 3 separate occasions. The data is presented as ± standard error and corrected for the non irradiated controls. 
Results
Impact of fractionation on cell survival
As seen in figure 2 both cell lines show an increase in cell survival after the fractionated uniform dose delivery when compared to acute exposure, even at the shortest time intervals (4 hrs). The lack of further repair as inter-fraction time increases indicates repair processes with a short half-time have a stronger impact on the overall survival. This also has effects on the in-field sparing, thus causing the survival fraction in-field to follow a similar trend to the uniform field irradiation.
As expected, fractionation has a significant effect on the beta component, (as seen in table 1).
For AGO-1522, it decreases from 0.023 Gy -2 for acute dose delivery to 0 for split dose irradiation, while α has no significant variation. MCF-7 cells show a decrease in β from 0.064
Gy -2 for single dose irradiation to 0.03 Gy -2 for split-dose irradiation. Within experimental uncertainties these observations agree with modelling fractionated exposures as 2 independent single fractions (which predict β for two-fraction exposures should be equal to a half that of a single exposure). Similar trends for α and β with dose fractionation have been reported elsewhere (van den Aardweg 2003).
DNA damage repair following exposure to fractionated radiation To assess how the inter-fraction time affects the DNA damage, contribution of the second fraction was kept constant by fixing the slides 30 minutes after the last irradiation. Figure 5b and c show the damage decay with half-lives of 4.07±0.5 h for MCF7 and 6.93± 0.8 h for AGO-1522. For the same time points in modulated configuration the DNA damage has a half life of 9.9 ±0.9 h for MCF7 and 0.5±0.12 h in AGO-1522 cell line ( Figure 6 ). Table 2 shows the variation of the DNA damage decay rates and half-times. It is important to note that the repair half time for uniform field and cell survival data indicate the 4 h time interval is very important in cell recovery for the investigated cell lines.
In both MCF-7 and AGO-1522 cells, no statistically significant difference was seen in DNA damage levels observed out-of-field with varying inter-fraction times. This suggests that no additional DNA damage accumulates after the delivery of the first fraction which is also consistent with the observed cell survival responses.
Discussion
Previous studies ( conditioned medium (ICCM) after fractionated exposure of donor cells to investigate the recovery pattern on recipient cells. Directly irradiated cells showed a significant recovery with dose fractionation, but recipient cells show no recovery with the dose split in two equal fractions by 3 hour time lapse. However, medium harvested from cells exposed to fractionated irradiation and added to non-irradiated cells reduced the survival below that seen for medium harvested from cells irradiated using a single-dose protocol. The authors reported that cells treated with media harvested from fractionated irradiation have a lower level of 'recovery factors' than those directly exposed to fractionated irradiation. This is consistent with the results presented here, pointing towards the lack of repair experienced by the out-of-field populations during variable inter-fraction exposure times.
The recovery kinetics observed in this work are in agreement with previous reports (Mariotti et al 2013) showing that cells have largely recovered by 6 hours after the first irradiation event.
Consequently, DNA damage induced by the second fraction is not enhanced by any residual damage, and cells react to it as a new single exposure.
While fractionation has a significant effect on uniformly exposed populations, the overall survival is influenced by the intercellular signalling occurring in the modulated field exposures.
The out-of-field populations have a different behaviour than the in-field cells at the DNA damage level, but this induces no significant change in the long term survival.
When delivering the dose as two equal fractions, the out-of-field response has, as previously established (Schettino et al 2005) , a binary behaviour, with populations of responding and nonresponding cells, reaching saturation at low out-of-field doses (<0.5 Gy). The lack of variation of the out-of-field responses with the inter-fraction interval suggests that the response is, as previously modelled (McMahon et al 2013a) , related to the amount of time the signal is above a threshold value and not to the total signal exposure.
The differing responses to fractionation between in-and out-of-field cells may have a significant impact on biological optimisation of fractionated radiotherapy. The effects of fractionation are typically understood through the partial or complete repair of sublethal damage with some characteristic half-life (T1/2) (Thames et al 1984) .
While these results are in agreement with this assumption for an individual exposure condition, they also suggest that, for the presented cell models, sublethal damage repair kinetics are not solely a function of a cell's intrinsic radiosensitivity, but also on whether it is directly exposed to ionising radiation, subject to bystander stress, or a combination of both effects. This is a significant departure from established models, and may need to be incorporated in future radiobiological treatment planning models to fully understand and optimise the therapeutic ratio through parameters such as fraction size and margin prescription.
Conclusion
The impact of dose fractionation cannot be assessed in isolation but must consider the complex relationship between tumour radiosensitivity and the normal tissue tolerance to the late effects of radiation. The results in this work indicate that conclusions from directly irradiated repair kinetics cannot be extrapolated directly to populations that are primarily exposed to out-offield scattered radiation, as signalling-driven damage has significantly different kinetics.
Considering the limitations of the model proposed here, further validation is required for a wider range of cell lines, different conditions, and in vivo, before their incorporation into robust treatment planning models as an important step towards the development of future biologically optimised treatment protocols. Table 1 . α and β parameters for AGO-1522 and MCF-7 for uniform field and exposed modulated field. 0h time point corresponds to single dose irradiation. Survival curve for uniform irradiation and modulated in-field were fitted by LQ model. figure 4a . Table 2B shows the decay rates for DNA damage for 2Gy delivered as two equal fractions in uniform field or shielded configurations (Fig 5b and c and   Fig 6) . 
